3rd Quarter - Report
HOOPER, LUNDY & BOOKMAN, P.C. for AVANIR PHARMACEUTICALS, INC.
Client
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA labeling of pharmaceutical, general pharmaceutical issues and monitoring of 21st Century Cures Act (H.R. 6) and Innovation for Healthier Americans initiative.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARTIN A CORRY | — |
| KELLY L. DELMORE | Legislative Assistant; Office of Phil English |
| MONICA MASSARO | — |
Medicare/Medicaid MMM
General Medicare coverage of pharmaceutical drugs and Medicare quality programs. Medicare specialty tier cap increase.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARTIN A CORRY | — |
| KELLY L. DELMORE | Legislative Assistant; Office of Phil English |
| MONICA MASSARO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.